EBA
BMY icon

Eagle Bay Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Eagle Bay Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$392K Buy
6,461
+166
+3% +$9.68K 0.35% 70
2025
Q4 		$340K Buy
6,295
+113
+2% +$5.44K 0.25% 74
2025
Q3 		$279K Sell
6,182
-293
-5% -$13.7K 0.22% 83
2025
Q2 		$300K Sell
6,475
-11
-0.2% -$540 0.25% 79
2025
Q1 		$396K Sell
6,486
-32
-0.5% -$1.86K 0.34% 60
2024
Q4 		$369K Sell
6,518
-199
-3% -$11.1K 0.23% 70
2024
Q3 		$348K Sell
6,717
-842
-11% -$39.5K 0.13% 121
2024
Q2 		$314K Sell
7,559
-611
-7% -$27.3K 0.19% 80
2024
Q1 		$443K Buy
8,170
+425
+5% +$21.6K 0.28% 61
2023
Q4 		$397K Sell
7,745
-312
-4% -$16.4K 0.25% 70
2023
Q3 		$468K Buy
8,057
+462
+6% +$28.3K 0.22% 67
2023
Q2 		$486K Sell
7,595
-492
-6% -$33K 0.28% 56
2023
Q1 		$560K Buy
8,087
+21
+0.3% +$1.48K 0.31% 50
2022
Q4 		$580K Sell
8,066
-240
-3% -$18.1K 0.33% 53
2022
Q3 		$591K Sell
8,306
-400
-5% -$29K 0.36% 49
2022
Q2 		$670K Buy
8,706
+457
+6% +$34.8K 0.41% 44
2022
Q1 		$602K Sell
8,249
-188
-2% -$12.6K 0.49% 33
2021
Q4 		$523K Sell
8,437
-2,089
-20% -$123K 0.33% 46
2021
Q3 		$623K Buy
10,526
+2,823
+37% +$186K 0.35% 43
2021
Q2 		$518K Buy
+7,703
New +$502K 0.42% 36

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Eagle Bay Advisors's BMY Position: Q1 2026 in Review

Eagle Bay Advisors increased its Bristol-Myers Squibb (BMY) stake by 2.6% in Q1 2026, buying an estimated $9.68K and bringing the position to 6,461 shares worth $392K. The position accounts for 0.35% of the portfolio, ranked #70.

Eagle Bay Advisors first reported a position in BMY in Q2 2021 and has held it in 20 quarters since. The position peaked at $670K in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Eagle Bay Advisors held 6,461 shares of Bristol-Myers Squibb worth $392K as of Q1 2026.
  • Eagle Bay Advisors bought 166 Bristol-Myers Squibb shares in Q1 2026, an estimated $9.68K.
  • Bristol-Myers Squibb made up 0.35% of Eagle Bay Advisors's portfolio in Q1 2026, its #70 holding.
  • Eagle Bay Advisors first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 20 quarters since.
  • Eagle Bay Advisors's Bristol-Myers Squibb position peaked at $670K in Q2 2022.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Eagle Bay Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.